Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3b, Multicenter, Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

NCT06855498 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.

NCT NCT06855498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06855498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3b, Multicenter, Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Lead sponsor
Incyte Corporation
Phase
Phase 3
Overall status
Recruiting
Start date
February 28, 2025
Completion date
February 28, 2028
Enrollment
600 (estimated)
Sites
296

Conditions

As the registry lists them; a condition with its own page is linked.

hidradenitis suppurativa (hs)